Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/32331

Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study


no-thumbnailView/Open:

 Personality and psychiatric disorders in chronic pain male affected.pdf



826,36 kB
Adobe PDF
Share:

This resource is restricted

Title:
Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study
Authors:
Ajo Ferrer, Raquel  
Inda, Maria del Mar
Mateu, Margarita
Segura, Ana
Ballester, Purificación
Muriel, Javier  
Sellers, Rafael
Ferrández, Guillermina
Margarit, César
Peiró, Ana  
Editor:
Springer Nature
Department:
Departamentos de la UMH::Farmacología, Pediatría y Química Orgánica
Issue Date:
2020-05
URI:
https://hdl.handle.net/11000/32331
Abstract:
The prevalence of personality disorders (PDs) and sexual dysfunction in chronic pain patients is higher than in general population. Our main objective was to analyse the influence of PD in patients with erectile dysfunction and chronic non-cancer pain and their response to andrological treatment. One-hundred one patients were included along 30 months. Pain intensity, quality of life, sexual life quality, anxiety and depression were analysed together with opioid dose. Erectile functioning was measured with the International Index of Erectile Function (IIEF) and PDs with Millon Clinical Multiaxial Inventory (MCMI-III). The mean age was 57 ± 12 years old, with moderate to severe pain, 70% were sexually active and presented moderate to severe ED. PDs were very frequent (31%, cut-off 85 and 84% cut-off 75 scores) mostly anxiety, compulsive, though disorder, somatoform and narcissistic. Self-defeating feature presence was significantly correlated (r = -0.4, 95% CI = -0.605 to -0.145, p = 0.002) with a more severe baseline ED and narcissistic, and a better response to andrological treatment (p = 0.010, d = 1.082). Patients with dysthymia features required significantly higher opioid doses vs. control (238 vs. 102 mg/day, respectively). These findings underline the importance of diagnosing PDs to rigorously treat patients with chronic pain and ED.
Knowledge area:
CDU: Ciencias aplicadas: Medicina: Farmacología. Terapéutica. Toxicología. Radiología
Type of document:
application/pdf
Access rights:
info:eu-repo/semantics/closedAccess
DOI:
https://doi.org/10.1038/s41443-020-0294-9
Appears in Collections:
Artículos Farmacología, Pediatría y Química Orgánica



Creative Commons ???jsp.display-item.text9???